Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

55.81USD
16 Feb 2018
Change (% chg)

$0.02 (+0.04%)
Prev Close
$55.79
Open
$56.33
Day's High
$56.33
Day's Low
$55.31
Volume
19,247
Avg. Vol
36,078
52-wk High
$56.77
52-wk Low
$21.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.50 1.10 0.00 --
Quarter Ending Jun-18 3 0.50 1.10 0.00 --
Year Ending Dec-18 5 2.08 4.24 0.80 3.12
Earnings (per share)
Quarter Ending Mar-18 3 -0.77 -0.62 -0.89 --
Quarter Ending Jun-18 3 -0.78 -0.62 -0.91 --
Year Ending Dec-18 6 -3.17 -2.48 -3.53 -2.78
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) 713.58 140.57 8.57
Price to Book (MRQ) 8.09 18.76 5.14
Price to Tangible Book (MRQ) 8.24 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 84.33 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -62.87 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -58.61 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -43.40 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -29.37 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 10.85 6.17 3.38
LT Debt to Equity (MRQ) 0.00 16.64 11.85
Total Debt to Equity (MRQ) 0.00 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -4,414.52 -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -4,445.49 -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -4,641.91 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -4,630.18 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 28,161 23,305,201 819,569,446
Net Income/Employee (TTM) -1,303,896 -626,600 95,804,981
Receivable Turnover (TTM) 5.31 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.01 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -68.76 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -76.78 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -76.78 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.31 11.40 77 71
13 Week 51.08 42.60 85 93
26 Week 100.04 77.58 88 86
52 Week 103.17 74.54 83 87
YTD 39.32 36.33 87 90
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.56%
# of Holders: 80
Total Shares Held: 30,388,104
3 Mo. Net Change: 1,315,717
# New Positions: 23
# Closed Positions: 17
# Increased Positions: 48
# Reduced Positions: 33
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.